✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹147 Cr.
P/E
209.41

Key Ratios

Market cap
Market cap
147 Cr
PE
PE
209
Prom Holding
Prom Holding
52.18 %
ROE (%)
ROE (%)
18.57
ROCE (%)
ROCE (%)
17.93
Div Yield (%)
Div Yield (%)
-
Sales
Sales
16.33 Cr
OPM (%)
OPM (%)
12.33 %
Debt to Equity
Debt to Equity
0.63

About

Auro Laboratories Limited, founded in 1992 in Mumbai, is a manufacturer of Active Pharmaceutic… Read more
Low
170
52W Range
High
303
  • Auro Laboratories
  • Parnax Lab
  • Vaishali Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Auro Laboratories Ltd. Business

Auro Laboratories Limited is a pharmaceutical company specializing in manufacturing Active Pharmaceutical Ingredients, Intermediates, and Generic Formulations, with a primary focus on Anti-Diabetic Drugs.

Auro Laboratories major competitors are Parnax Lab, Smruthi Organics, Tyche Inds, Krebs Biochem.&Inds, Vaishali Pharma, Quest Laboratories, Bal Pharma.
Market Cap of Auro Laboratories is ₹148 Crs.
While the median market cap of its peers are ₹147 Crs.

Auro Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Auro Laboratories is 3.65 and is ranked 5 out of its 8 competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material